• United States

U.S. Pharma Stocks Analysis

NasdaqGM:EOLS
NasdaqGM:EOLS
NasdaqGM:EOLSPharmaceuticals

Evolus, Inc. (NASDAQ:EOLS) insiders who sold US$2.4m worth of stock earlier this year are probably glad they did so as market cap slides to US$573m

May 10, 2022
Over the past year, insiders sold US$2.4m worth of Evolus, Inc. ( NASDAQ:EOLS ) stock at an average price of US$10.69...
NasdaqGM:QLI
NasdaqGM:QLI
NasdaqGM:QLIPharmaceuticals

Is Qilian International Holding Group Limited's (NASDAQ:QLI) Recent Price Movement Underpinned By Its Weak Fundamentals?

May 10, 2022
Qilian International Holding Group (NASDAQ:QLI) has had a rough three months with its share price down 28%. We, however...
NasdaqCM:PLXP
NasdaqCM:PLXP
NasdaqCM:PLXPPharmaceuticals

Is PLx Pharma (NASDAQ:PLXP) In A Good Position To Deliver On Growth Plans?

May 10, 2022
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
NasdaqGM:OCUL
NasdaqGM:OCUL
NasdaqGM:OCULPharmaceuticals

Is Ocular Therapeutix (NASDAQ:OCUL) Using Too Much Debt?

May 10, 2022
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
NYSE:TARO
NYSE:TARO
NYSE:TAROPharmaceuticals

Taro Pharmaceutical Industries' (NYSE:TARO five-year decrease in earnings delivers investors with a 63% loss

May 10, 2022
Generally speaking long term investing is the way to go. But along the way some stocks are going to perform badly. For...
NasdaqGM:FULC
NasdaqGM:FULC
NasdaqGM:FULCPharmaceuticals

These Analysts Think Fulcrum Therapeutics, Inc.'s (NASDAQ:FULC) Sales Are Under Threat

May 10, 2022
Market forces rained on the parade of Fulcrum Therapeutics, Inc. ( NASDAQ:FULC ) shareholders today, when the analysts...
NYSE:BMY
NYSE:BMY
NYSE:BMYPharmaceuticals

Investing in Bristol-Myers Squibb (NYSE:BMY) three years ago would have delivered you a 79% gain

May 09, 2022
By buying an index fund, you can roughly match the market return with ease. But many of us dare to dream of bigger...
NasdaqGS:NGM
NasdaqGS:NGM
NasdaqGS:NGMPharmaceuticals

Analysts Are Betting On NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) With A Big Upgrade This Week

May 09, 2022
Celebrations may be in order for NGM Biopharmaceuticals, Inc. ( NASDAQ:NGM ) shareholders, with the analysts delivering...
NasdaqGS:ATHA
NasdaqGS:ATHA
NasdaqGS:ATHAPharmaceuticals

Companies Like Athira Pharma (NASDAQ:ATHA) Are In A Position To Invest In Growth

May 08, 2022
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
Last
  • 3
  • 4
  • 5
  • 6
  • 7
Next

Make Confident Investment Decisions

Simply Wall St's Editorial Team provides unbiased, factual reporting on global stocks using in-depth fundamental analysis.
Find out more about our editorial guidelines and team.

Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
  • About
  • Company
  • Careers
  • Plans
  • Log In
  • Help Centre
  • Latest Coverage
  • Podcasts
  • Financial Services Guide
  • Terms and Conditions
  • Privacy Policy

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.